Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

2.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.1K
Peptic Ulcer01:27

Peptic Ulcer

31
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
31
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

793
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
793
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.7K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.7K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.1K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

651
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
651

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Video Capsule Endoscopy Replace Biopsy in the Diagnosis of Celiac Disease?

The Israel Medical Association journal : IMAJ·2026
Same author

[Treatment Safety and Risk Management in Medicine Taught in Medical Schools in Israel, Compared to the U.S.]

Harefuah·2026
Same author

Freezing while preserving achievements: suspending quality indicators in healthcare, Israel's experience.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2025
Same author

Comparison of Outcomes of Chronic Obstructive Pulmonary Disease Patients Hospitalized in Hospital-at-Home vs. In-hospital Settings: A Systematic Review and Meta-analysis.

The Israel Medical Association journal : IMAJ·2025
Same author

Polyp detection rate changed between shifts.

The Israel Medical Association journal : IMAJ·2025
Same author

Decrease in Calcifications After Neoadjuvant Treatment Predicts Invasive Tumor Response but Not Complete DCIS Eradication: Systematic Review and Meta-Analysis.

Clinical breast cancer·2025

Related Experiment Video

Updated: Apr 5, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

894

Do "Developing" Countries Become "Developed"? Lessons from Helicobacter pylori Infection Recurrence Rate after

Yaron Niv1

  • 1Adelson Faculty of Medicine, Ariel University, Ariel, Israel, nivy@ariel.ac.il.

Digestive Diseases (Basel, Switzerland)
|April 3, 2026
PubMed
Summary
This summary is machine-generated.

The disparity in Helicobacter pylori infection recurrence between developed and developing nations has vanished. This suggests that H. pylori recurrence may indicate socioeconomic status, reflecting global development trends.

Keywords:
EradicationHelicobacter pyloriRecrudescenceRecurrenceReinfection

More Related Videos

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

1.2K
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

442

Related Experiment Videos

Last Updated: Apr 5, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

894
Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

1.2K
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

442

Area of Science:

  • Global Health
  • Infectious Diseases
  • Socioeconomic Indicators

Background:

  • Helicobacter pylori infection affects over half the global population, with prevalence varying significantly by country.
  • Recurrence after eradication can occur through recrudescence or reinfection.
  • The World Bank defines developing countries based on income, but socioeconomic factors also refine this classification.

Purpose of the Study:

  • To compare the recurrence rates of Helicobacter pylori infection in developed versus developing countries.
  • To investigate whether Helicobacter pylori recurrence rates can serve as an indicator of socioeconomic development.

Main Methods:

  • Comparative analysis of two meta-analyses conducted in 2008 and 2024.
  • Inclusion of data on Helicobacter pylori eradication and recurrence rates.
  • Consideration of country classifications (developed vs. developing) based on World Bank income criteria.

Main Results:

  • A significant decrease in the disparity of Helicobacter pylori recurrence rates between developed and developing countries was observed between 2008 and 2024.
  • The study found that Helicobacter pylori recurrence rates are no longer a distinguishing factor between these country groups.

Conclusions:

  • The disappearance of the gap in H. pylori recurrence rates suggests a convergence in health outcomes related to this infection.
  • This convergence may reflect the ongoing socioeconomic development of formerly developing nations.
  • Helicobacter pylori recurrence could potentially serve as a marker for a nation's socioeconomic transition.